Alexander Labrunerie & CO. Inc. Increases Stake in Oracle Corporation $ORCL

Alexander Labrunerie & CO. Inc. raised its stake in shares of Oracle Corporation (NYSE:ORCLFree Report) by 4.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,354 shares of the enterprise software provider’s stock after buying an additional 101 shares during the quarter. Alexander Labrunerie & CO. Inc.’s holdings in Oracle were worth $515,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of ORCL. Redmont Wealth Advisors LLC bought a new position in shares of Oracle during the 1st quarter valued at approximately $27,000. Iron Horse Wealth Management LLC boosted its position in shares of Oracle by 284.9% during the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider’s stock valued at $29,000 after acquiring an additional 151 shares during the last quarter. LGT Financial Advisors LLC bought a new position in shares of Oracle during the 2nd quarter valued at approximately $33,000. Legend Financial Advisors Inc. bought a new position in shares of Oracle during the 2nd quarter valued at approximately $34,000. Finally, HighMark Wealth Management LLC bought a new position in shares of Oracle during the 2nd quarter valued at approximately $38,000. 42.44% of the stock is currently owned by institutional investors.

Oracle Stock Down 0.7%

NYSE:ORCL opened at $281.25 on Tuesday. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The company has a market cap of $801.78 billion, a price-to-earnings ratio of 65.10, a price-to-earnings-growth ratio of 3.04 and a beta of 1.53. The stock has a fifty day simple moving average of $275.24 and a 200-day simple moving average of $222.60. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCLGet Free Report) last released its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same quarter last year, the business posted $1.39 earnings per share. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is 46.30%.

Analysts Set New Price Targets

A number of research analysts have recently commented on ORCL shares. Scotiabank increased their target price on Oracle from $350.00 to $360.00 and gave the company an “outperform” rating in a research report on Friday, October 17th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $310.00 target price on shares of Oracle in a research report on Friday, October 17th. Cantor Fitzgerald increased their target price on Oracle from $271.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday, September 10th. Stephens raised their price target on Oracle from $208.00 to $331.00 and gave the stock an “equal weight” rating in a research report on Friday, October 17th. Finally, Mizuho raised their price target on Oracle from $300.00 to $350.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 10th. Three analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $323.69.

Read Our Latest Report on ORCL

Insider Buying and Selling at Oracle

In other news, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the sale, the insider directly owned 132,656 shares in the company, valued at approximately $42,603,800.96. This trade represents a 20.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Naomi O. Seligman sold 2,222 shares of Oracle stock in a transaction dated Friday, September 26th. The shares were sold at an average price of $288.91, for a total value of $641,958.02. Following the completion of the sale, the director owned 29,225 shares of the company’s stock, valued at $8,443,394.75. The trade was a 7.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 170,769 shares of company stock valued at $50,297,667. 40.90% of the stock is owned by company insiders.

About Oracle

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Further Reading

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.